Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP714218.RAHzl6u-b217-Osn_tAloSp5W35b2ii4wm_qbVWlf9umI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP714218.RAHzl6u-b217-Osn_tAloSp5W35b2ii4wm_qbVWlf9umI130_assertion type Assertion NP714218.RAHzl6u-b217-Osn_tAloSp5W35b2ii4wm_qbVWlf9umI130_head.
- NP714218.RAHzl6u-b217-Osn_tAloSp5W35b2ii4wm_qbVWlf9umI130_assertion description "[These obstacles call for other strategies of metastases management, such as arresting or differentiating agents, some of which have been successfully tested by the author's group, such as antiprostaglandins, antithrombin, somatostatin, hyaluronidase, and retinoic acid.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP714218.RAHzl6u-b217-Osn_tAloSp5W35b2ii4wm_qbVWlf9umI130_provenance.
- NP714218.RAHzl6u-b217-Osn_tAloSp5W35b2ii4wm_qbVWlf9umI130_assertion evidence source_evidence_literature NP714218.RAHzl6u-b217-Osn_tAloSp5W35b2ii4wm_qbVWlf9umI130_provenance.
- NP714218.RAHzl6u-b217-Osn_tAloSp5W35b2ii4wm_qbVWlf9umI130_assertion SIO_000772 2403488 NP714218.RAHzl6u-b217-Osn_tAloSp5W35b2ii4wm_qbVWlf9umI130_provenance.
- NP714218.RAHzl6u-b217-Osn_tAloSp5W35b2ii4wm_qbVWlf9umI130_assertion wasDerivedFrom befree-20150227 NP714218.RAHzl6u-b217-Osn_tAloSp5W35b2ii4wm_qbVWlf9umI130_provenance.
- NP714218.RAHzl6u-b217-Osn_tAloSp5W35b2ii4wm_qbVWlf9umI130_assertion wasGeneratedBy ECO_0000203 NP714218.RAHzl6u-b217-Osn_tAloSp5W35b2ii4wm_qbVWlf9umI130_provenance.